A higher level of LRP1 protein may be associated with a higher endocytosis of upregulated transporter proteins at the cell surface, which is likely the cause of increased doxorubicin and emodin (an anti-inflammatory agent) accumulation and growth inhibition in lung adenocarcinoma and colorectal carcinoma cells [62]. Here, LRP1 is linked to lung adenocarcinoma.